Citations

Showing 10 of 108094 citations.

Factors Associated With Psychological Readiness to Return to Sport After Anterior Cruciate Ligament Reconstruction Surgery
Nagelli, Christopher V. , Hewett, Timothy E. , Feller, Julian A. , Webster, Kate E.

Mayo Clinic

The American Journal of Sports Medicine | May 2, 2018 | Volume: 46 | Issue: 7 | Pages: 1545-1550

10.1177/0363546518773757 | PMID 29718684 Get It

Background: Anterior cruciate ligament (ACL) injury has a significant psychological effect, and a negative psychological state is a commonly cited reason for a reduction or cessation of sports participation after ACL reconstruction (ACLR) surgery. Purpose: To identify factors that contribute to an athlete’s psychological readiness to return to sport (RTS) after ACLR. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A cohort of 635 athletes (389 male, 246 female) who underwent ACLR and had been cleared to RTS completed the Anterior Cruciate Ligament–Return to Sport After Injury (ACL-RSI) scale at an average 12 months (range, 11-24 months) after surgery. Demographics (age, sex), sporting outcomes (preinjury frequency), surgical timing (injury to surgery interval), clinical factors (laxity), functional measures (single-limb hop symmetry), and symptoms of pain and function (International Knee Documentation Committee subjective) were also taken, and univariate and multiple regression models were used to determine the association between these and the psychological readiness of the athlete to RTS (ACL-RSI scores). Data for the entire cohort were initially analyzed; then, patients were grouped according to whether they had returned to competitive sport, and the analysis repeated for each group (return/nonreturn). Results: Univariate analysis for the entire group showed that all of the following had a positive effect on psychological readiness: male sex (β = 5.8; 95% CI, 2-10), younger age (β = −0.2; 95% CI, –0.4 to 0.01), a shorter interval between injury and surgery (β = −0.1; 95% CI, −0.1 to −0.02), a higher frequency of preinjury sport participation (β = 5.4; 95% CI, 2-9), greater limb symmetry (β = 0.5; 95% CI, 0.3-0.6), and higher subjective knee scores (β = 1.3; 95% CI, 1.1-1.4). In the multivariate model, subjective knee scores and age significantly accounted for 37% of the variance in psychological readiness ( r 2 = 0.37, P < .0001). The only difference between the groups who had and had not returned to sport was that female sex was a significant contributor for the nonreturn group. Conclusion: Self-reported symptoms and function were most associated with psychological readiness to RTS after ACLR surgery. Male patients who participated frequently in sport before ACL injury had higher psychological readiness. Conversely, female patients had a more negative outlook and may therefore benefit more from interventions designed to facilitate a smooth transition back to sport.
Globular Glial Tauopathy May be Mistaken for Corticobasal Syndrome—Pointers for the Clinician
Marsili, Luca , Espay, Alberto J. , Espay, Alberto J , Dickson, Dennis W.

Mayo Clinic

Movement Disorders Clinical Practice | May 2, 2018 | Volume: 5 | Issue: 4 | Pages: 439-441

10.1002/mdc3.12634 | PMID 30838299 Get It

View Supplementary Video 1View Supplementary Video 2
The bigger they are the harder they fall: size‐dependent vulnerability of motor neurons in amyotrophic lateral sclerosis
Fogarty, Matthew J. , Fogarty, Matthew J , Fogarty, Matthew J

Mayo Clinic

The Journal of Physiology | May 2, 2018 | Volume: 596 | Issue: 13 | Pages: 2471-2472

10.1113/jp276312 | PMID 29719046 Get It

A phase 1 study of eribulin mesylate (E7389), a novel microtubule‐targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)
Schafer, Eric S. , Rau, Rachel E. , Liu, Xiaowei , D’Adamo, David R., Scott, Rachael , Reyderman, Larisa, Martinez, Gresel, Devarajan, Sandhya, Fox, Elizabeth , Weigel, Brenda J. , Blaney, Susan M. , Reid, Joel M. , Schafer, Eric S , Berg, Stacey L. , Minard, Charles G.

Mayo Clinic

Pediatric Blood & Cancer | May 2, 2018 | Volume: 65 | Issue: 8 | Pages: No page available

10.1002/pbc.27066 | PMID 29719113 Get It

Abstract Background Eribulin mesylate is a novel anticancer agent that inhibits microtubule growth, without effects on shortening, and promotes nonproductive tubulin aggregate formation. We performed a phase 1 trial to determine the dose‐limiting toxicities (DLTs), maximum tolerated or recommended phase 2 dose (MTD/RP2D), and pharmacokinetics (PK) of eribulin in children with refractory or recurrent solid (excluding central nervous system) tumors. Methods Eribulin was administered intravenously on days 1 and 8 in 21‐day cycles. Three dose levels (1.1, 1.4, and 1.8 mg/m 2 /dose) were evaluated using the rolling six design with additional patients enrolled into a PK expansion cohort at the MTD. PK samples were obtained following the day 1, cycle 1 dose. Results Twenty‐three patients, ages 3–17 (median 14) years were enrolled; 20 were evaluable for toxicity. DLTs occurred in 0/6 and 1/6 subjects at the 1.1 and 1.4 mg/m 2 /dose, respectively. One subject at the 1.4 mg/m 2 /dose had grade 4 neutropenia and grade 3 fatigue. At the 1.8 mg/m 2 /dose, 2/5 subjects experienced dose‐limiting (grade 4) neutropenia. Grade 3/4 non‐DLTs included lymphopenia and hypokalemia, while low‐grade toxicities included anorexia and nausea. No episodes of grade > 2 corrected QT interval prolongation or peripheral neuropathy were reported. Eribulin pharmacokinetic parameters were highly variable; the median elimination half‐life was 39.6 (range 24.2–96.4) hr. A partial response was observed in one patient (Ewing sarcoma). Conclusions Eribulin was well tolerated in children with refractory or recurrent solid tumors with neutropenia identified as the primary DLT. The RP2D of eribulin is 1.4 mg/m 2 /dose on days 1 and 8 of a 21‐day cycle.
Oversight and Ethical Regulation of Conflicts of Interest in Neurosurgery in the United States
DiRisio, Aislyn C. , Muskens, Ivo S. , Coté, David J. , Babu, Maya , Gormley, William B. , Smith, Timothy R. , Moojen, Wouter A. , Broekman, Marike L. D.

Mayo Clinic

Neurosurgery | May 2, 2018 | Volume: 84 | Issue: 2 | Pages: 305-312

10.1093/neuros/nyy227 | PMID 29850841 Get It

Abstract BACKGROUND Developmental incentives are fundamental to surgical progress, yet financial and professional incentives inherently create conflicts of interest (COI). Understanding how to manage COI held by neurosurgeons, industry, hospitals, and journal editors, without thwarting progress and innovation is critical. OBJECTIVE To present an overview of COI associated with innovation in neurosurgery, and review ways to manage these in an ethically sound manner. METHODS A review of the literature was performed to assess conflicts of interest that affect neurosurgical innovation, and review ways to manage COI of various parties while adhering to ethical standards. RESULTS COI are inherent to collaboration and innovation, and are therefore an unavoidable component of neurosurgery. The lack of a clear distinction between clinical practice and innovation, ability to use devices off-label, and unstandardized disclosure requirements create inconsistencies in the way that conflicts of interest are handled. Additionally, lack of requirements to compare innovation to the standard of care and inherent bias that affects study design and interpretation can have profound effects on the medical literature. Conflicts of interest can have both direct and downstream effects on neurosurgical practice, and it is possible to manage them while improving the quality of research and innovation. CONCLUSION Conflicts of interest are inherent to surgical innovation, and can be handled in an ethically sound manner. Neurosurgeons, device companies, hospitals, and medical journals can take steps to proactively confront bias and ensure patient autonomy and safety. These steps can preserve public trust and ultimately improve evidence-based neurosurgical practice.
Editorial Commentary: “Virtual Reality” Simulation in Orthopaedic Surgery: Realistically Helpful, or Virtually Useless?
Camp, Christopher L. , Camp, Christopher L.

Mayo Clinic

Arthroscopy | May 2, 2018 | Volume: 34 | Issue: 5 | Pages: 1678-1679

10.1016/j.arthro.2018.02.042 | PMID 29729767 Get It

Abstract Although we have come a long way, the rapidly expanding field of virtual reality simulation for arthroscopic surgical skills acquisition is supported by only a limited amount of evidence. That said, the good news is that the evidence suggests that simulator experience translates into improved performance in the operating room. If proving this relation is our ultimate goal, more work is certainly needed. In this commentary, a “Task List” is proposed for surgeons and educators interested in using simulators and better defining their role in resident education.
Functional outcomes in patients with co-occurring traumatic brain injury and spinal cord injury from an inpatient rehabilitation facility’s perspective
Garlanger, Kristin, Garlanger, Kristin L, Beck, Lisa A. , Cheville, Andrea

Mayo Clinic

The Journal of Spinal Cord Medicine | May 1, 2018 | Volume: 41 | Issue: 6 | Pages: 718-730

10.1080/10790268.2018.1465744 | PMID 29714644 Get It

Conservation of Mannan Synthesis in Fungi of the Zygomycota and Ascomycota Reveals a Broad Diagnostic Target
Burnham‐Marusich, Amanda R. , Hubbard, Breeana, Kvam, Alexander J., Gates‐Hollingsworth, Marcellene A., Green, Heather R. , Soukup, Eric, Kozel, Thomas R. , Limper, Andrew H.

Mayo Clinic

mSphere | May 1, 2018 | Volume: 3 | Issue: 3 | Pages: No page available

10.1128/msphere.00094-18 | PMID 29720523 Get It

A key question asked when faced with an infection, an infestation, or environmental damage is whether it is a fungus. Identification of fungi as the cause of the problem can lead to remediation or treatment. Zygomycetes and ascomycetes account for the vast majority of fungal causes of human, animal, and plant disease, large-scale biodiversity loss, agricultural spoilage, and contamination of water-damaged buildings. These studies revealed the conservation of a common cell wall structural component of zygomycetes and ascomycetes to be a diagnostic target applicable to multiple pathogenic fungi and have leveraged that insight for practical use. Monoclonal antibodies reactive with this pan-fungal structure were produced and used to construct immunoassays (including ELISA and lateral flow assay) for detection of a broad range of pathogenic fungi.
Outcome of long benign esophageal strictures undergoing endoscopictherapy: a tertiary center experience
Pang, Maoyin , Brand, Eelco C. , Brahmbhatt, Bhaumik , Patel, Krupa , Simons-Linares, C. Roberto , Wolfsen, Herbert C. , Wallace, Michael B. , Woodward, Timothy A., Wallace, Michael B , Bartel, Michael J. , Raimondo, Massimo

Mayo Clinic

Diseases of the Esophagus | May 1, 2018 | Volume: 31 | Issue: 10 | Pages: No page available

10.1093/dote/doy040 | PMID 29718161 Get It

Practical Guidance for Clinical Microbiology Laboratories: Implementing a Quality Management System in the Medical Microbiology Laboratory
Carey, Roberta B., Bhattacharyya, Sanjib , Kehl, Sue C., Matukas, Larissa , Pentella, Michael , Salfinger, Max , Schuetz, Audrey N.

Mayo Clinic

Clinical Microbiology Reviews | May 1, 2018 | Volume: 31 | Issue: 3 | Pages: No page available

10.1128/cmr.00062-17 | PMID 29720490 Get It

SUMMARY This document outlines a comprehensive practical approach to a laboratory quality management system (QMS) by describing how to operationalize the management and technical requirements described in the ISO 15189 international standard. It provides a crosswalk of the ISO requirements for quality and competence for medical laboratories to the 12 quality system essentials delineated by the Clinical and Laboratory Standards Institute. The quality principles are organized under three main categories: quality infrastructure, laboratory operations, and quality assurance and continual improvement. The roles and responsibilities to establish and sustain a QMS are outlined for microbiology laboratory staff, laboratory management personnel, and the institution's leadership. Examples and forms are included to assist in the real-world implementation of this system and to allow the adaptation of the system for each laboratory's unique environment. Errors and nonconforming events are acknowledged and embraced as an opportunity to improve the quality of the laboratory, a culture shift from blaming individuals. An effective QMS encourages “systems thinking” by providing a process to think globally of the effects of any type of change. Ultimately, a successful QMS is achieved when its principles are adopted as part of daily practice throughout the total testing process continuum.